Geode Capital Management’s Tenax Therapeutics TENX Stock Holding History

Geode Capital Management’s Portfolio TENX Stock Details TENX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.11M	Buy	69,160 +13,461	+24%	+$182K	﹤0.01%	3333
2025 Q4	$679K	Buy	55,699 +21,274	+62%	+$185K	﹤0.01%	3490
2025 Q3	$262K	Buy	34,425 +189	+0.6%	+$1.15K	﹤0.01%	3840
2025 Q2	$200K	Buy	34,236 +895	+3%	+$5.17K	﹤0.01%	3869
2025 Q1	$218K	Buy	33,341 +8,987	+37%	+$57.6K	﹤0.01%	3818
2024 Q4	$151K	Buy	24,354 +5,964	+32%	+$28.9K	﹤0.01%	3982
2024 Q3	$63.6K	Buy	18,390 +7,349	+67%	+$26.6K	﹤0.01%	4214
2024 Q2	$33.6K	Buy	+11,041	New	+$39.1K	﹤0.01%	4363
2024 Q1	–	Sell	-1,851	Closed	-$40.7K	–	4635
2023 Q4	$40.7K	Buy	1,851 +364	+24%	+$8.74K	﹤0.01%	4403
2023 Q3	$35.1K	Buy	+1,487	New	+$37.7K	﹤0.01%	4512
2023 Q1	–	Sell	-32	Closed	-$6K	–	4830
2022 Q4	$6K	Hold	32	–	–	﹤0.01%	4879
2022 Q3	$8K	Hold	32	–	–	﹤0.01%	5003
2022 Q2	$15K	Hold	32	–	–	﹤0.01%	4959
2022 Q1	$41K	Hold	32	–	–	﹤0.01%	4842
2021 Q4	$53K	Hold	32	–	–	﹤0.01%	4850
2021 Q3	$90K	Hold	32	–	–	﹤0.01%	4700
2021 Q2	$111K	Sell	32 -1	-3%	-$3.17K	﹤0.01%	4532
2021 Q1	$99K	Buy	33 +12	+57%	+$42.8K	﹤0.01%	4304
2020 Q4	$61K	Hold	21	–	–	﹤0.01%	4134
2020 Q3	$50K	Hold	21	–	–	﹤0.01%	4016
2020 Q2	$29K	Hold	21	–	–	﹤0.01%	4049
2020 Q1	$18K	Hold	21	–	–	﹤0.01%	4043
2019 Q4	$46K	Hold	21	–	–	﹤0.01%	4100
2019 Q3	$39K	Hold	21	–	–	﹤0.01%	4092
2019 Q2	$45K	Buy	21 +4	+24%	+$9.68K	﹤0.01%	4093
2019 Q1	$55K	Hold	17	–	–	﹤0.01%	4005
2018 Q4	$33K	Buy	+17	New	+$93.5K	﹤0.01%	4049
2018 Q1	–	Sell	-2	Closed	-$36K	–	4077
2017 Q4	$36K	Sell	2 -1	-33%	-$13.6K	﹤0.01%	3958
2017 Q3	$31K	Hold	3	–	–	﹤0.01%	3986
2017 Q2	$64K	Hold	3	–	–	﹤0.01%	3917
2017 Q1	$51K	Hold	3	–	–	﹤0.01%	3945
2016 Q4	$177K	Hold	3	–	–	﹤0.01%	3658
2016 Q3	$208K	Hold	3	–	–	﹤0.01%	3584
2016 Q2	$232K	Hold	3	–	–	﹤0.01%	3536
2016 Q1	$186	Hold	3	–	–	﹤0.01%	3656
2015 Q4	$297K	Hold	3	–	–	﹤0.01%	3510
2015 Q3	$252K	Hold	3	–	–	﹤0.01%	3571
2015 Q2	$296K	Hold	3	–	–	﹤0.01%	3432
2015 Q1	$262K	Hold	3	–	–	﹤0.01%	3474
2014 Q4	$308K	Hold	3	–	–	﹤0.01%	3401
2014 Q3	$316K	Hold	3	–	–	﹤0.01%	3376
2014 Q2	$328K	Buy	3 +1	+50%	+$154K	﹤0.01%	3342
2014 Q1	$427K	Buy	+2	New	+$396K	﹤0.01%	3217

Other funds holding TENX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Geode Capital Management's TENX Position: Q1 2026 in Review

Geode Capital Management increased its Tenax Therapeutics (TENX) stake by 24% in Q1 2026, buying an estimated $182K and bringing the position to 69,160 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #3333.

Geode Capital Management first reported a position in TENX in Q1 2014 and has held it in 43 quarters since. 80 funds tracked by Wall St. Rank hold TENX as of Q1 2026.

Geode Capital Management held 69,160 shares of Tenax Therapeutics worth $1.11M as of Q1 2026.
Geode Capital Management bought 13,461 Tenax Therapeutics shares in Q1 2026, an estimated $182K.
Tenax Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3333 holding.
Geode Capital Management first reported a position in Tenax Therapeutics in Q1 2014 and has held it in 43 quarters since.
80 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.